Publications by authors named "Arvind Mer"

Claim this Profile
G
Global DNA methylation signatures associated with chemoresistance and poor prognosis of high grade serous ovarian cancer.
Hafiza Bushra Manzoor, Melisa Acun, Hamed Yasavoli-Sharahi, Chantal Matar, Arvind Mer

Sci Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spotlight on nuclear PD-L1 in ovarian cancer chemoresistance: hidden but mighty.
Meshach Asare-Werehene, Arvin Zaker, Shivanshi Tripathi, Laudine Communal, Euridice Carmona, Arvind Mer

Front Immunol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the diversity of type IV secretion system-encoding plasmids in .
Farah Nasser, Avery Gaudreau, Shareefah Lubega, Arvin Zaker, Xuhua Xia, Arvind S Mer

Emerg Microbes Infect· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural insights into an atypical histone binding mechanism by a PHD finger.
Sabrina Grégoire, Janelle Grégoire, Yidai Yang, Sabrina Capitani, Monika Joshi, Arvind Mer

Structure· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Text-mining-based feature selection for anticancer drug response prediction.
Grace Wu, Arvin Zaker, Amirhosein Ebrahimi, Shivanshi Tripathi, Arvind Singh Mer

Bioinform Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential DNA damage repair and PARP inhibitor vulnerability of the mammary epithelial lineages.
Hyeyeon Kim, Kazeera Aliar, Pirashaanthy Tharmapalan, Curtis W McCloskey, Abhijith Kuttanamkuzhi, Luis Palomero, Arvind S Mer

Cell Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatiotemporal modeling of chemoresistance evolution in breast tumors uncovers dependencies on SLC38A7 and SLC46A1.
Yannick Audet-Delage, Catherine St-Louis, Lucía Minarrieta, Shawn McGuirk, Irwin Kurreal, Arvind Singh Mer

Cell Rep· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential DNA damage repair and PARP inhibitor vulnerability of the mammary epithelial lineages.
Hyeyeon Kim, Kazeera Aliar, Pirashaanthy Tharmapalan, Curtis W McCloskey, Abhijith Kuttanamkuzhi, Luis Palomero, Arvind S Mer

Cell Rep· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large-scale phenogenomic analysis of human cancers uncovers frequent alterations affecting SMC5/6 complex components in breast cancer.
Shamayita Roy, Arvin Zaker, Arvind Mer, Damien D'Amours

NAR Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bimodal Gene Expression in Patients with Cancer Provides Interpretable Biomarkers for Drug Sensitivity.
Wail Ba-Alawi, Sisira Kadambat Nair, Bo Li, Anthony Mammoliti, Petr Smirnov, Arvind Singh Mer

Cancer Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IPO11 regulates the nuclear import of BZW1/2 and is necessary for AML cells and stem cells.
Boaz Nachmias, Dilshad H Khan, Veronique Voisin, Arvind S Mer, Geethu Emily Thomas, Aaron D Schimmer

Leukemia· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer.
Chewei Anderson Chang, Jayu Jen, Shaowen Jiang, Azin Sayad, Arvind Singh Mer

Cancer Discov· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PharmacoDB 2.0: improving scalability and transparency of in vitro pharmacogenomics analysis.
Nikta Feizi, Sisira Kadambat Nair, Petr Smirnov, Gangesh Beri, Christopher Eeles, Arvind Singh Mer

Nucleic Acids Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug sensitivity prediction from cell line-based pharmacogenomics data: guidelines for developing machine learning models.
Hossein Sharifi-Noghabi, Soheil Jahangiri-Tazehkand, Petr Smirnov, Casey Hon, Anthony Mammoliti, Arvind Singh Mer

Brief Bioinform· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing therapy response in patient-derived xenografts.
Janosch Ortmann, Ladislav Rampášek, Elijah Tai, Arvind Singh Mer, Ruoshi Shi

Sci Transl Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orchestrating and sharing large multimodal data for transparent and reproducible research.
Anthony Mammoliti, Petr Smirnov, Minoru Nakano, Zhaleh Safikhani, Christopher Eeles, Arvind S Mer

Nat Commun· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteogenomic characterization of pancreatic ductal adenocarcinoma.
Liwei Cao, Chen Huang, Daniel Cui Zhou, Yingwei Hu, T Mamie Lih, Arvind Singh Mer

Cell· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highlights from the 16th International Society for Computational Biology Student Council Symposium 2020.
Wim L Cuypers, Handan Melike Dönertaş, Jasleen K Grewal, Nazeefa Fatima, Chase Donnelly, Arvind Singh Mer

F1000Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel subtypes of -mutated AML with distinct outcome.
Arvind Singh Mer, Mark D Minden, Benjamin Haibe-Kains, Aaron D Schimmer

Mol Cell Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological and therapeutic implications of a unique subtype of NPM1 mutated AML.
Arvind Singh Mer, Emily M Heath, Seyed Ali Madani Tonekaboni, Nergiz Dogan-Artun, Sisira Kadambat Nair, Aaron D Schimmer

Nat Commun· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer.
Ruoshi Shi, Nikolina Radulovich, Christine Ng, Ni Liu, Hirotsugu Notsuda, Arvind Singh Mer

Clin Cancer Res· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts.
Arvind S Mer, Wail Ba-Alawi, Petr Smirnov, Yi X Wang, Ben Brew

Cancer Res· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression levels of long non-coding RNAs are prognostic for AML outcome.
Arvind Singh Mer, Johan Lindberg, Christer Nilsson, Daniel Klevebring, Mei Wang

J Hematol Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative cancer pharmacogenomics to establish drug mechanism of action: drug repurposing.
Nehme El-Hachem, Wail Ba-Alawi, Ian Smith, Arvind Singh Mer, Benjamin Haibe-Kains

Pharmacogenomics· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Software for the Integration of Multiomics Experiments in Bioconductor.
Marcel Ramos, Lucas Schiffer, Angela Re, Rimsha Azhar, Azfar Basunia, Arvind S Mer

Cancer Res· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis